Search by Drug Name or NDC

    NDC 68382-0469-77 Desvenlafaxine 50 mg/1 Details

    Desvenlafaxine 50 mg/1

    Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DESVENLAFAXINE.

    Product Information

    NDC 68382-0469
    Product ID 68382-469_281d1f1b-df9d-4c11-86c3-df47e59fe8b0
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Desvenlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desvenlafaxine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204020
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0469-77 (68382046977)

    NDC Package Code 68382-469-77
    Billing NDC 68382046977
    Package 10 BLISTER PACK in 1 CARTON (68382-469-77) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68382-469-30)
    Marketing Start Date 2018-05-08
    NDC Exclude Flag N
    Pricing Information N/A